UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Kensington Investment Counsel LLC

Kensington Investment Counsel LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 5.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,787 shares of the healthcare conglomerate’s stock after purchasing an additional 141 shares during the quarter. Kensington Investment Counsel LLC’s holdings in UnitedHealth Group were worth $1,405,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Robbins Farley acquired a new position in shares of UnitedHealth Group in the third quarter worth about $25,000. NewSquare Capital LLC lifted its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares in the last quarter. Strategic Investment Solutions Inc. IL acquired a new position in shares of UnitedHealth Group in the first quarter worth about $35,000. Annapolis Financial Services LLC raised its stake in UnitedHealth Group by 38.6% during the third quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock valued at $40,000 after buying an additional 22 shares in the last quarter. Finally, WFA of San Diego LLC acquired a new stake in UnitedHealth Group during the second quarter valued at approximately $39,000. Institutional investors and hedge funds own 85.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on UNH shares. UBS Group upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $520.00 to $640.00 in a research note on Monday, October 16th. Oppenheimer restated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Jefferies Financial Group lowered their target price on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating for the company in a report on Monday, November 20th. Stephens reaffirmed an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a report on Thursday. Finally, Morgan Stanley lowered their target price on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating for the company in a report on Monday, October 23rd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $575.79.

Check Out Our Latest Report on UnitedHealth Group

Insider Activity

In other news, Director Stephen J. Hemsley sold 66,081 shares of the stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the completion of the sale, the director now owns 635,528 shares in the company, valued at approximately $349,788,255.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $518.22 on Friday. The stock has a fifty day moving average price of $525.36 and a two-hundred day moving average price of $517.77. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.80 and a current ratio of 0.79. The firm has a market cap of $479.31 billion, a P/E ratio of 21.74, a PEG ratio of 1.41 and a beta of 0.54. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. During the same period last year, the company posted $5.34 EPS. The firm’s quarterly revenue was up 14.1% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 27.84 EPS for the current fiscal year.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.